{
    "title": "111_hr1230",
    "content": "The Act titled \"Acquired Bone Marrow Failure Disease Research and Treatment Act of 2010\" amends the Public Health Service Act to include a section on research for acquired bone marrow failure diseases. The Secretary may conduct research on acquired bone marrow failure diseases, including trends in diagnosis, genetic and environmental factors, treatment approaches, outcomes, and other relevant factors. The Secretary may collaborate with the Radiation Injury Treatment Network to augment data for studies on acquired bone marrow failure diseases, access technical assistance, and perform joint research projects. Acquired bone marrow failure diseases include myelodysplastic syndromes, aplastic anemia, paroxysmal nocturnal hemoglobinuria, and pure red cell aplasia. The Secretary may specify bone marrow failure diseases acquired and not inherited, such as pure red cell aplasia, acute myeloid leukemia from myelodysplastic syndromes, and large granular lymphocytic leukemia. SEC. 3. Minority-focused programs on acquired bone marrow failure diseases are added to Title XVII of the Public Health Service Act. The Secretary may establish outreach programs for minority populations affected by acquired bone marrow failure diseases, providing information on treatment options and clinical trials. SEC. 317V of the Public Health Service Act authorizes grants for researching best practices in diagnosing and caring for individuals with acquired bone marrow failure diseases. The document is attested by Lorraine C. Miller, the Clerk."
}